Blackstone has reportedly teamed up with healthcare conglomerate Danaher Corp to take on private equity competitors in multibillion-dollar bidding for Johnson & Johnson’s diagnostics unit Ortho Clinical.
The consortium is up against Bain Capital, Carlyle, BC Partners and a joint bid from Leonard Green & Partners and CVC Capital according to Reuters, which cited people familiar with the matter.
It said J&J received preliminary offers for Ortho in September and was now seeking a new round of bids by November 11.
J&J had initially hoped to make as much as $5bn from the sale, but potential buyers are now valuing the business closer to $4bn, some of the sources said.
Earlier this year J&J teamed up with Index Ventures and GlaxoSmithKline to launch a €150m fund focused on the life sciences sector.
Copyright © 2013 AltAssets